Study Stopped
Study has been completed in terms of duration but no patient has been recruited during this time
Use of Hand Prosthesis With Direct Nerve Stimulation for Treatment of Phantom Limb Pain
EPIONE
Natural Sensory Feedback for Phantom Limb Modulation and Therapy
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
Phantom limb pain (PLP) is a frequent consequence of amputation, and it is notoriously difficult to treat. Amputation usually follows traumatic injuries or surgery following vascular diseases, diabetes, osteomyelitis or tumours in cases where the loss of the limb is required for the survival of the patient. The loss of a limb or other body parts is usually followed by the sensation that the lost body part is still present and can be felt. These phenomena are called, respectively, phantom awareness and phantom sensation. In 50-80% of amputees neuropathic pain develops in the lost limb also referred to as phantom limb pain (PLP). PLP can be related to a certain position or movement of the phantom limb, and might be elicited or worsened by a range of physical factors (e.g. changes in the weather or pressure on the residual limb) and psychological factors (e.g. emotional stress). It is well known that most treatments available for PLP today, such as pharmacological, surgical, anaesthetic, psychological and other, are ineffective. Today it is believed that phantom limb pain may be related to changes in the cortex of the brain. There is evidence that these changes may be modulated - or even reversed - by providing sensory input to the stump or amputation zone. For example, cortical reorganization and alleviation of phantom limb pain has been observed in amputees following intense use of a hand prosthesis. However, there is no consistent knowledge on which type of peripheral sensory feedback may be effective in affecting the cortical plasticity or on how to best apply the sensory feedback. The aim of the proposed research is to create natural, meaningful sensations through providing invasive sensory feedback (i.e. electrical stimulation through intraneural implantation of electrodes) and the effectiveness to alleviate phantom limb pain and restore the cortical neuroplastic changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 30, 2016
CompletedFirst Posted
Study publicly available on registry
June 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedNovember 14, 2017
November 1, 2017
1.5 years
May 30, 2016
November 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Phantom limb pain (questionnaires)
The pain intensity will be assessed using visual analog scale (VAS)
Change in phantom limb pain perception during the all study (from baseline to maximum 6 months)
Cortical reorganization (fMRI)
The cortical response to peripheral stimulation will be tracked using fMRI
Change in cortical reorganization before and at the end of treatment (from baseline to maximum 6 months)
Secondary Outcomes (2)
Phantom limb pain (questionnaires)
Change in neuropathic pain symptoms during the all study (from baseline to maximum 6 months)
Cortical reorganization (EEG)
Change in cortical reorganization before and at the end of treatment (from baseline to maximum 6 months)
Study Arms (1)
Operation of hand prosthesis with direct nerve stimulation
EXPERIMENTALA system composed by the integration of the following non-CE marked medical devices specifically designed for the study will be used in one or two amputees: * STIMEP (multichannel electrical stimulator for the peripheral nervous system; AXONIC) * TIME-4H Intraneural Electrodes (ALBERT-LUDWIGS-UNIVERSITAET FREIBURG) * Sensorized Hand Prosthetics for amputees IH2 Prosthetic Azurra Prensilia (Prensilia Ltd.) * Prosthetics sensorized hand for amputees DLR/HIT Hand II (Wessling Robotics) * ODROID software integration within the afferent and efferent bi-directional control of the robotic hand * The EPIONE Psychophysical Testing Platform software for stimulator control
Interventions
Four TIME-4H electrodes will be implanted in the median and ulnar nerves of the amputees. The electrodes will be connected with the STIMEP electrical multichannel stimulator. The stimulator will be connected with one of the two sensorized hand prosthesis. Afferent and efferent signals will be elaborated and integrated by the ODROID software. The amputees will be able to control the prosthetic hand movement and receive a sensory feedback from the prosthesis sensors. The use of the prosthesis during different tasks will be considered the intervention.
Eligibility Criteria
You may qualify if:
- Unilateral transradial amputation.
- Amputation should be in the chronic, stable phase, such that the stump has healed and the person apart from eventual phantom pain (PLP) is healthy and able to carry out experiments.
- Other treatments for PLP tried with poor results.
- Patient accepts the study protocol as explained by the physician.
- The subject experienced intractable PLP of more than 6 on NRS or VAS (0-10 scale). The frequency of PLP episodes presents more than once a week.
You may not qualify if:
- Cognitive impairment
- Current or prior psychological impairments: Major personality disturbance (i.e. borderline, antisocial), Major depression, Bipolar I.
- Pregnancy
- History of or active substance abuse disorder
- Acquired brain injury with residual impairment
- Intellectual Disability (IQ \< 70)
- Prior neurological or musculoskeletal disease
- Current or prior dermatological conditions
- Excessive sensitivity to electrical stimulation with surface electrodes. People afraid of electrical stimulation or pain.
- People with other diseases which may affect the function of the nervous system. (Diabetes, HIV, Renal Failure)
- Patients implanted with pacemakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prof. Wassim Raffoullead
- Aalborg University Hospitalcollaborator
- University of Freiburgcollaborator
- Université Montpelliercollaborator
- Lund Universitycollaborator
- Indiana University School of Medicinecollaborator
- Novosense ABcollaborator
- Mxm-Obeliacollaborator
- Ecole Polytechnique Fédérale de Lausannecollaborator
- Universitat Autonoma de Barcelonacollaborator
- Catholic University of the Sacred Heartcollaborator
- Aalborg Universitycollaborator
Study Sites (1)
University of Lausanne Hospital CHUV
Lausanne, Canton of Vaud, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wassim Raffoul, Professor
University Hospital Lausanne CHUV
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 30, 2016
First Posted
June 10, 2016
Study Start
May 1, 2016
Primary Completion
November 1, 2017
Study Completion
November 1, 2017
Last Updated
November 14, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will share
The laws on protection and data sharing is currently being analysed by one of the consortium partners